Researchers from Uppsala University in Sweden have built a new tool to identify patients who are at high-risk of coronary artery disease and could benefit from new, intensive preventive treatments.

Coronary artery disease is characterised by arteriosclerosis that constricts coronary arteries in the heart, leading to oxygen deficiency and chest pains.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The disease is considered as one of the most common causes of death, while the risk of dying from this disease is said to vary with individuals.

In a study involving 13,164 patients with stable coronary artery disease, the researchers constructed a model that could predict the risk of dying from the disease with high accuracy.

Uppsala Clinical Research Centre Medical Sciences department Daniel Lindholm said: “This tool could make it possible to give patients with coronary artery disease a more precise and tailor-made treatment.

“The tool makes it possible to identify those who have the highest risk.”

“The tool makes it possible to identify those who have the highest risk.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

During the study, NT-proBNP and high-sensitivity cardiac Troponin T blood tests were found to reveal more prognosis information.

Present only in cardiac muscle cells, lower levels of Troponin T protein can be measured with highly sensitive methods to obtain prognostic information in a stable phase, while NT-proBNP is secreted by the heart during stressed conditions such as heart failure and stable coronary artery disease.

The researchers combined these blood tests with certain clinical factors to construct the tool, which was able to accurately predict the risk of death and onset of heart failure due to the disease.


Image: Two blood tests have been found to reveal more information about the prognosis for coronary artery disease than any other factor studied. Photo: courtesy of Uppsala University.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact